Al Wattar, BH;
Rogozińska, E;
Vale, C;
Fisher, D;
Petersen, I;
Nicum, S;
Bannington, D;
... Freemantle, N; + view all
(2024)
Effectiveness and safety of menopause treatments: pitfalls of available evidence and future research need.
Climacteric
10.1080/13697137.2023.2297880.
(In press).
![[thumbnail of Freemantle_Pitfalls of evidence synthesis for menopause treatments submission.pdf]](https://discovery.ucl.ac.uk/style/images/fileicons/text.png) |
Text
Freemantle_Pitfalls of evidence synthesis for menopause treatments submission.pdf Access restricted to UCL open access staff until 27 January 2025. Download (353kB) |
Abstract
By 2050 more than 1.6 billion women worldwide will be of post-reproductive age, with >75% reporting severe menopausal symptoms. The last few years saw a gradual uplift in public awareness reaffirming the health needs of women with menopause. Still, effective translation of available evidence on menopause treatments is hindered by several methodological limitations and poor research conduct. We argue that a paradigm shift is required in menopause research to address the remaining knowledge gap and guide safe evidence-based care provision. A critical misconception across studies on menopause is the assumption that women represent a homogeneous group who respond similarly to a particular therapy irrespective of their exposure and individual risk factors. We highlight potential solutions to optimize the quality of future research in menopause including adopting robust trial methodology, standardize outcome reporting to capture quality-of-life measures, and improve lay patient and public involvement in future research.
Archive Staff Only
 |
View Item |
